This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy Co-Diagnostics stock in Canada | $12.12

Own Co-Diagnostics shares in just a few minutes.

Updated . What changed?

Fact checked

Co-Diagnostics, Inc is a diagnostics & research business based in the US. Co-Diagnostics shares (CODX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $12.12 – a decrease of 13.43% over the previous week. Co-Diagnostics employs 39 staff and has a trailing 12-month revenue of around $47.5 million.

How to buy shares in Co-Diagnostics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: CODX in this case.
  5. Research Co-Diagnostics shares. The platform should provide the latest information available.
  6. Buy your Co-Diagnostics shares. It's that simple.

How has Coronavirus impacted Co-Diagnostics's share price?

Since the stock market crash in March caused by coronavirus, Co-Diagnostics's share price has had significant positive movement.

Its last market close was $12.12, which is 74.83% up on its pre-crash value of $3.05 and 396.72% up on the lowest point reached during the March crash when the shares fell as low as $2.44.

If you had bought $1,000 worth of Co-Diagnostics shares at the start of February 2020, those shares would have been worth $3,153.30 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $4,039.96.

Co-Diagnostics share price

Use our graph to track the performance of CODX stocks over time.

Co-Diagnostics shares at a glance

Information last updated 2020-12-02.
Latest market close $12.12
52-week range $0.88 - $29.99
50-day moving average $12.9739
200-day moving average $15.951
Wall St. target price $30.67
PE ratio 10.0063
Dividend yield N/A (0%)
Earnings per share (TTM) $1.122

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Buy and sell thousands of US and Canadian stocks and ETFs commission-free with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, Mutual Funds, ETFs, Currencies, Futures, Precious Metals
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are equal to or greater than US$10.00)
Min. $1.00, Max. 0.5% of trade value
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, IPOs, Precious Metals
$4.95 - $9.95
$9.95 + $1 per contract
$0
Free
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
loading

Compare up to 4 providers

Name Product Minimum deposit to invest Funding methods Management fee Available asset types
CI Direct Investing (formerly WealthBar)
$1,000
Direct deposit, Bank transfer
0.35% - 0.60%
Mutual Funds, ETFs
CI Direct Investing offers access to an exclusive and personalized investment portfolio. Get up to $10,000 managed free for a year when you sign up for your first CI Direct Investing account and fund your account.
Moka
$0
Automatic bank withdrawals
$3/month
ETFs
The Moka app rounds up every purchase you make to the nearest dollar and invests the spare change into low-cost exchange-traded funds (ETFs).
Justwealth
$5,000
Direct deposit, Bank transfer, Automatic bank withdrawals
0.50%
ETFs
Receive a cash bonus of $50.00-$225.00 when you open a new Justwealth account. RESP accounts require no minimum deposit to begin investing.
Wealthsimple Invest
$1
Direct deposit, Bank transfer
0.40% - 0.50%
Stocks, Bonds, ETFs, Commodities
Get a $50 bonus when you open and fund your first Wealthsimple Invest account with a minimum initial deposit of at least $500. Trade and Cash accounts are not eligible.
loading

Compare up to 4 providers

Name Product Minimum Opening Deposit Commission Available Markets Platforms
Forex.com
US$100
Minimum US$25
Forex
Metals
Commodities
Indices
Shares
Forex.com Desktop, Forex.com Web Trading, Forex.com Mobile Trading, MetaTrader 4
CFDs are leveraged products which involves greater risk than using cash resources only. You could lose all or more of your initial investment. Trade 80+ currency pairs and 220+ CFDs in equities, commodities and indices on Forex.com.
loading

Compare up to 4 providers

Is it a good time to buy Co-Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Co-Diagnostics price performance over time

Historical closes compared with the last close of $12.12

1 week (2020-11-27) 1.93%
1 month (2020-11-05) -16.41%
3 months (2020-09-04) 47.09%
6 months (2020-06-05) -24.16%
1 year (2019-12-05) 1,124.24%
2 years (2018-12-04) 442.52%
3 years (2017-12-05) 160.65%

Is Co-Diagnostics under- or over-valued?

Valuing Co-Diagnostics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Co-Diagnostics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Co-Diagnostics's P/E ratio

Co-Diagnostics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Co-Diagnostics shares trade at around 10x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Co-Diagnostics's EBITDA

Co-Diagnostics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$24.1 million.

The EBITDA is a measure of a Co-Diagnostics's overall financial performance and is widely used to measure a its profitability.

Co-Diagnostics financials

Revenue TTM USD$47.5 million
Operating margin TTM 50.6%
Gross profit TTM USD$102,543
Return on assets TTM 51.4%
Return on equity TTM 99.58%
Profit margin 58.79%
Book value $1.874
Market capitalisation USD$317.4 million

TTM: trailing 12 months

How to short and sell Co-Diagnostics shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "CODX.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 6.9 million Co-Diagnostics shares held short by investors – that's known as Co-Diagnostics's "short interest". This figure is 7.5% up from 6.5 million last month.

There are a few different ways that this level of interest in shorting Co-Diagnostics shares can be evaluated.

Co-Diagnostics's "short interest ratio" (SIR)

Co-Diagnostics's "short interest ratio" (SIR) is the quantity of Co-Diagnostics shares currently shorted divided by the average quantity of Co-Diagnostics shares traded daily (recently around 1.7 million). Co-Diagnostics's SIR currently stands at 3.98. In other words for every 100,000 Co-Diagnostics shares traded daily on the market, roughly 3980 shares are currently held short.

However Co-Diagnostics's short interest can also be evaluated against the total number of Co-Diagnostics shares, or, against the total number of tradable Co-Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Co-Diagnostics's short interest could be expressed as 0.25% of the outstanding shares (for every 100,000 Co-Diagnostics shares in existence, roughly 250 shares are currently held short) or 0.2457% of the tradable shares (for every 100,000 tradable Co-Diagnostics shares, roughly 246 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Co-Diagnostics.

Find out more about how you can short Co-Diagnostics stock.

Co-Diagnostics share dividends

We're not expecting Co-Diagnostics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Co-Diagnostics share price volatility

Over the last 12 months, Co-Diagnostics's shares have ranged in value from as little as $0.88 up to $29.99. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Co-Diagnostics's is -1.5938. This would suggest that Co-Diagnostics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Co-Diagnostics has bucked the trend.

Co-Diagnostics overview

Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site